Regeneron to buy Sanofi’s stake in joint project for $900M

Giugno 2, 2022

Regeneron Pharmaceuticals Inc. announced on Wednesday that it will buy Sanofi S.A.’s stake in their joint Libtayo medicine program.

Under the deal, Regeneron will first pay $900 million to Sanofi…